XianJun He
LiLing Lu- Department of Radiology, Minzu Hospital of Guangxi Zhuang Autonom, Nanning, China
This study explores the imaging diagnosis and differential diagnosis of pleomorphic adenoma (PA) of the breast. PA is a rare benign tumor of the breast with a risk of recurrence, though it rarely undergoes malignant transformation. Therefore, extensive local excision is often performed, and a correct preoperative diagnosis of this lesion is important to ensure appropriate surgical treatment. Due to its rarity and nonspecific imaging findings, preoperative diagnosis is challenging and prone to misdiagnosis, especially in patients with a history of other malignancies. We present the case of a patient with a history of gastric cancer (GC) who presented with a breast mass that was pathologically confirmed to be PA. We analyzed the tumor’s imaging and pathological characteristics and discussed the diagnostic strategy.
1 Introduction
Pleomorphic adenoma (PA) is the most common benign tumor among salivary gland tumors. It most commonly occurs in the parotid gland. It is a tumor containing epithelial, myxoid, chondroid, and other tissues, with obvious pleomorphism and mixed shapes, and so it is called a pleomorphic adenoma or mixed tumor (1, 2). PA occurring in the breast is extremely rare. PA of the breast is classified as an epithelio-myoepithelial tumor, exhibiting unique histological features, including myoepithelial differentiation and a mucinous, cartilaginous-like matrix. Other benign breast tumors include adenomas, fibroepithelial tumors, hamartomas, papillary tumors, and more. Adenomas encompass tubular adenomas, lactating adenocarcinomas, and more. The more common fibroadenomas and phyllodes tumors fall under fibroepithelial tumors. Due to its rarity and tendency to be confused with fibroadenoma, phyllodes tumor, or mucinous carcinoma, PA of the breast can be challenging to distinguish on imaging studies, making preoperative diagnosis difficult. PA of the breast tends to occur in middle-aged and elderly women, with most reported cases occurring in individuals over 40 years of age, with the predilection site being in the subareolar area (3). However, there are few relevant imaging reports (4–8), and preoperative diagnosis is difficult. Therefore, this article aims to report a case of pathologically confirmed PA of the breast, focusing on its detailed imaging features on enhanced CT and MRI and combined with the patient’s history of gastric cancer (GC) to explore its differential diagnosis ideas and clinical management strategies.
2 Case report
The patient, a 66-year-old woman, with no family history of breast tumors, complained of a 2-day-old left breast tumor, about the size of a peanut, with no ulceration, pus, redness, swelling, or pain. Six months ago, the patient underwent a subtotal gastrectomy for gastric adenocarcinoma. Physical examination revealed a palpable mass in the outer lower quadrant of the left breast, approximately 20 to 30 mm in size, hard in consistency, with indistinct boundaries, irregular surface, fixed to underlying tissue, no obvious tenderness, and no local skin flushing or ulceration. No enlarged lymph nodes were palpable in the bilateral axillary and supraclavicular fossa. Ultrasound shows that, as shown in Figure 1, a hypoechoic nodule can be detected at the junction of the lower outer quadrant of the left breast and the areola, with a size of approximately 24 mm × 13 mm, irregular shape, angular edges, uneven internal echo, and no blood flow detected. It is classified as BI-RADS 4a. Contrast-enhanced CT showed an equal-density soft tissue nodule in the outer lower quadrant of the left breast as shown in Figure 2, 5 mm away from the nipple. The enhanced scan showed mild and uniform enhancement in the arterial phase and delayed enhancement in the venous phase and delayed phase, the edge of the lesion was unclear, and no calcification or cystic changes were found in the lesion. In the MRI plain scan + dynamic enhanced image in Figure 3, the lesion is shown to be isointense on the T1WI sequence; T2WI showed high signal with fat suppression, DWI showed high signal, and ADC showed high signal. The ADC value was about 1.5 × 10-3. There was no obvious diffusion restriction. The dynamic enhanced scan showed obvious uniform enhancement. The enhancement curve was inflow type or plateau type. The edge of the lesion was lobulated and the boundary was clear. The preoperative clinical and radiological preliminary diagnosis was a benign breast tumor, with a high possibility of fibroadenoma. The differential diagnosis also included phyllodes tumors, mucinous carcinomas, and metastases combined with the patient’s history of gastric cancer. Even though breast metastases are rare, they cannot be completely ruled out. Finally, the patient underwent breast lumpectomy, and pathology and immunohistochemistry confirmed pleomorphic adenoma of the breast (Figure 4). Due to the short postoperative period, long-term imaging follow-up data are still being collected for this case.
Figure 1. Ultrasound of left breast lesion. Preoperative ultrasound shows a hypoechoic nodule at the junction of the outer lower quadrant of the left breast and the areola, approximately 24 mm × 13 mm in size, with irregular shape, angular edges, uneven internal echo, and no blood flow detected. It is classified as BI-RADS 4a.
Figure 2. Chest CT plain + enhanced. (A) Plain scan phase, (B) arterial phase, (C) venous phase, (D) delayed phase, (E, F) venous phase sagittal, (G, H) venous phase. Coronal outside left breast first-order density soft tissue nodules were seen in the quadrant, 5 mm distant from the breast. An enhanced scan showed mild and uniform enhancement in the arterial phase and delayed enhancement in the venous and delayed phases. The edge of the lesion was unclear, and no calcification was found within it.
Figure 3. MRI plain scan + enhancement of left breast. (A) T1WI. (B–E) DCE at 1, 2, 4, 5, and 7 min, respectively. (F) TIC curve. (G) T2WI-FS. (H) DWI. (I) ADC. Left breast, outer inferior quadrant: The anterior view shows a nodular area with slightly longer T1 and T2 signal, lobulated shape, and with smooth edges and clear boundaries. DWI presents high signal intensity. ADC presents high signal intensity, with an ADC value of approximately 1.5 × 10-3. No significant diffusion restriction was observed. Dynamic enhancement scan shows obvious uniform enhancement, with an enhancement curve of inflow or plateau type.
Figure 4. Pathological image. (A) Low-power microscopy (HE staining, 4 × 10). (B) Immunohistochemical staining (p63 positive). Microscopic examination: The tumor is composed of glandular epithelium and myoepithelial components, with glandular epithelial cells arranged in tubular, solid nests, or papillary structures, with some cells showing mild atypia. The myoepithelium is composed of spindle or stellate cells, distributed around the glandular epithelium. The stroma is mainly mucinous and chondromatous, with partial areas showing ossification. The lesion is consistent with salivary gland-like tumors, considered to be PA. The immunohistochemical expression is as follows: CK5/6 (+), P63 (basal cells+), SMA (myoepithelial+), CD117 (+), CK7 (+), and KI-67 (positive rate 5%).
3 Diagnosis and differential diagnosis
3.1 Imaging diagnostic analysis
Based on the multimodal imaging findings of this case, we have extracted the following key features:
1. Morphology: The ultrasound shows irregular shape and angular edges, while MRI shows clear boundaries and lobulated edges, suggesting that the tumor has a certain degree of atypicality but overall shows an expansive growth pattern (7). The ultrasound often shows ill-defined lesion margins due to interference from surrounding glandular tissue, echo attenuation, and interface reflections. In contrast, T2WI fat-saturation sequence of MRI clearly revealed the high signal intensity of the mucinous stroma, thereby more accurately delineating the lobulated margins and expansile growth pattern of pleomorphic adenomas.
2. Signal/density characteristics: The plain CT scan shows isodense findings, while the T2WI fat-saturation sequence of MRI shows a significant high signal; this feature is particularly prominent.
3. Hemodynamics: CT and MRI dynamic enhancement scans show progressive and uniform enhancement, with time–signal intensity curves (TIC) as “inflow type”.
4. Diffusion characteristics: DWI shows a high signal, but the ADC map signal is also increased, with ADC values of about 1.5 × 10-3, suggesting no diffusion restriction.
3.2 Differential diagnosis
Based on the patient’s age and history of gastric cancer, it needs to be differentiated from the following lesions:
1. Fibroadenoma: Common benign tumor, but the typical T2WI signal is often slightly low or isodense, and there are often septa (9), rarely showing the significant high signal as in this case, and its shape is usually more regular.
2. Breast metastasis: Combined with the history of GC, this is an important differential point. The core of differentiation that lies in the T2WI of metastases is often of moderate to low signal, and usually there is diffusion restriction usually presenting as ring enhancement (10, 11), which is completely different from the imaging features of this case. In addition, there is no axillary lymph node enlargement in this case, which also supports it as a primary lesion.
3. Phyllode tumor of the breast: This is a greater challenge for differentiation, as it can also show as T2WI high signal and lobulated, but lobular tumors are usually larger in size, grow faster, and are prone to cystic degeneration or necrosis internally, with more significant and uneven enhancement, which is different from the uniform enhancement in this case (12).
4. Mucinous carcinoma: This is also characterized by significant T2WI high signal. The key difference lies in the dense cell areas of mucinous carcinoma causing diffusion restriction, and the enhancement is often characteristically “peripheral enhancement” or uneven enhancement (13), which is inconsistent with the findings in this case. The breast tumor in this case was pathologically confirmed as PA without malignant features; thus, no further genetic testing was performed. However, in clinical practice, patients with concurrent gastric and breast cancers (especially invasive lobular carcinoma) should be evaluated for hereditary syndromes such as hereditary diffuse gastric cancer (HDGC). Screening for CDH1 gene mutations and genetic counseling are recommended.
5. Lymphoma/leukemia breast involvement: This often presents as a palpable, painful mass, frequently multiple, commonly located in the upper outer quadrant, accompanied by axillary lymph node enlargement. On mammography, it typically appears as a poorly defined mass; ultrasound may show it as hyperechoic or hypoechoic with heterogeneous echogenicity. MRI commonly reveals an irregularly shaped mass with mild heterogeneous enhancement, TIC as “outflow type”, and restricted diffusion (10).
Preoperative comprehensive imaging evaluation, especially the characteristic T2WI significant high signal, no diffusion restriction, and benign enhancement pattern of MRI, strongly suggests a benign tumor rich in mucinous matrix, and pleomorphic adenoma should be considered, but it is difficult to completely exclude lobular tumor. The final diagnosis depends on pathological confirmation.
4 Discussion
PA usually occur in the salivary glands and rarely in the breast. PA of the breast was first reported in 1906 (14). PA of the breast are pathologically characterized by a mixture of epithelial/myoepithelial components and myxoid stroma/chondroid components (15). PA of the salivary glands and pleomorphic adenomas of the breast share many of the same pathological and MRI imaging features, such as clear borders, obvious high signal on T2WI, and no obvious diffusion restriction. These features are considered to be related to the rich myxoid stroma (13). This patient showed obvious high signal on T2WI, which is also because the stroma of the lesion is dominated by myxoid and chondroid stroma, and this is also one of the important points of differentiation from fibroadenoma, which is common in the breast. To date, fewer than 100 cases of pleomorphic adenoma of the breast have been reported, with even fewer imaging studies available. Table 1 shows a list of selected cases describing partial imaging features (primarily ultrasound) of pleomorphic adenoma of the breast.
Table 1. This case and previously reported cases of the imaging features of PA of the breast.
Shuichi Ito et al. (4) once reported a case of MRI manifestations of breast pleomorphic adenoma. It was an oval mass in the left breast with smooth borders. It was composed of solid and cystic components. There was no diffusion restriction. The TIC of the solid part was inflow or plateau type. The difference in this case was that the lesion was smaller and no cystic part was found. This case demonstrates combined features from ultrasound, contrast-enhanced CT, DCE-MRI, and DWI/ADC. Compared to most literature reporting only a single imaging modality, it more comprehensively reflects the imaging–pathology correlation—specifically the high T2 signal and absence of diffusion restriction—resulting from the abundant mucinous/cartilaginous matrix in PA of the breast. Secondly, unlike previous cases, this patient had a history of GC. Therefore, we must differentiate this from breast metastases. Breast metastases are mainly treated with adjuvant therapy, and the treatment effect is poor, the prognosis is poor, and the survival period is short (17). Primary extramammary tumors are mainly gastric cancer and lung cancer in Asia, while melanoma, lung cancer, and ovarian cancer are the main tumors in Europe and America. Leukemia and lymphoma are also common primary tumors (18). MRI appears like benign tumors, with smooth edges, no burrs, and lobulation, but diffusion is often limited, T2WI signal is low, TIC curves are mostly flat or outflow type, often accompanied by axillary lymph node enlargement, and the lymphatic hilum is unclear (10). In this case, the T2WI signal was obviously high and there was no obvious diffusion restriction. The axillary lymph nodes were not enlarged. The imaging findings are inconsistent with metastatic lesions. With advances in genomics technology, next-generation sequencing (NGS) performed on tissue biopsies or liquid biopsies can further aid in differential diagnosis. Pleomorphic adenomas may carry characteristic gene rearrangements (e.g., PLAG1 or HMGA2), while primary breast cancers or metastatic tumors typically exhibit distinct mutation profiles, such as TP53 mutations (common in triple-negative and high-grade cancers) and PIK3CA hotspot mutations (e.g., E542K, E545K, H1047R, present in approximately 30%–40% of HR+/HER2− breast cancers) (19, 20). When tissue sampling is limited, plasma ctDNA analysis can also identify systemic malignancies. Although NGS testing was not performed in this case due to a pathologically confirmed benign diagnosis, recognizing the potential value of these genomic tools is particularly important in patients with a history of other malignancies. This can help guide treatment decisions and avoid overtreatment.
5 Conclusion
We report a case of PA of the breast with the goal of improving people’s understanding of its imaging characteristics, which is characterized by a significantly high signal on T2WI and no diffusion restriction on MRI. For patients with a history of malignant tumors, recognizing these characteristics can help distinguish them from breast metastases and other breast tumors, providing the correct diagnostic direction for the clinic, thereby avoiding over-treatment and misdiagnosis for patients. However, the final diagnosis depends on pathological confirmation.
Data availability statement
The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.
Ethics statement
The studies involving humans were approved by Ethical Review Committee of Minzu Hospital of Guangxi Zhuang Autonom. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article. Written informed consent was obtained from the participant/patient(s) for the publication of this case report.
Author contributions
XJH: Methodology, Writing – review & editing. LLL: Data curation, Writing – original draft.
Funding
The author(s) declared that financial support was not received for this work and/or its publication.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Almeslet AS. Pleomorphic adenoma: A systematic review. Int J Clin Pediatr Dent. (2020) 13:284–7. doi: 10.5005/jp-journals-10005-1776
2. Kalwaniya DS, Meena R, Kumar D, Tolat A, and Arya SV. A review of the current literature on pleomorphic adenoma. Cureus. (2023) 15:e42311. doi: 10.7759/cureus.42311
3. Leekha N, Muralee M, Mathews A, Preethi TR, and Ahamed MI. Pleomorphic adenoma of breast-a case report and review of literature. Indian J Surg Oncol. (2014) 5:152–4. doi: 10.1007/s13193-014-0310-y
4. Ito S, Kawabata K, Kanagaki M, Taji T, Muro K, and Kimura H. A case of pleomorphic adenoma of the breast on dynamic contrast-enhanced MR imaging. Radiol Case Rep. (2022) 17:1158–62. doi: 10.1016/j.radcr.2022.01.022
5. Arslan A, Güldoğan N, Kapucuoğlu N, Esen G, Kara H, and Uras C. A rare case of pleomorphic adenoma of the breast: Ultrasonography and pathology findings. Breast J. (2018) 24:1069–70. doi: 10.1111/tbj.13133
6. Teh J, Dessauvagie B, Kessell M, Dissanayake D, and Wylie EJ. An atypically located pleomorphic adenoma: Radiological and pathological correlation. J Med Imag Rad Onc. (2022) 66:105–6. doi: 10.1111/1754-9485.13178
7. Sonagli M, Flora GTLD, Domingos TA, Cardona VF, Carvalho SMTD, Osório CABDT, et al. Pleomorphic adenoma of the breast. Mastology. (2021) 31:1–7. doi: 10.29289/2594539420200064
8. Ginter PS, Scognamiglio T, Tauchi-Nishi P, Antonio LB, and Hoda SA. Pleomorphic adenoma of breast: a radiological and pathological study of a common tumor in an uncommon location. Case Rep Pathol. (2015) 2015:172750. doi: 10.1155/2015/172750
9. Hochman MG, Orel SG, Powell CM, Schnall MD, Reynolds CA, and White LN. Fibroadenomas: MR imaging appearances with radiologic-histopathologic correlation. Radiology. (1997) 204:123–9. doi: 10.1148/radiology.204.1.9205233
10. Bitencourt AGV, Gama RRM, Graziano L, Negrão EMS, Sabino SMPS, Watanabe AHU, et al. Breast metastases from extramammary Malignancies: multimodality imaging aspects. Br J Radiol. (2017) 90:20170197. doi: 10.1259/bjr.20170197
11. Pesce K, Chico MJ, Sanabria Delgado J, Zabala Sierra AC, Hadad C, and Wernicke A. Metastases to the breast, an uncommon diagnosis: What do radiologists need to know? Radiología (English Edition). (2019) 61:324–32. doi: 10.1016/j.rxeng.2019.05.003
12. Balaji R and Ramachandran KN. Magnetic resonance imaging of a benign phyllodes tumor of the breast. Breast Care (Basel). (2009) 4:189–91. doi: 10.1159/000220604
13. Westra C, Dialani V, Mehta TS, Eisenberg RL, Westra C, Dialani V, et al. Using T2-weighted sequences to more accurately characterize breast masses seen on MRI. Am J Roentgenology. (2014) 202:W183–W190. doi: 10.2214/AJR.13.11266
15. Reid-Nicholson M, Bleiweiss I, Pace B, Azueta V, and Jaffer S. Pleomorphic adenoma of the breast. A case report and distinction from mucinous carcinoma. Arch Pathol Lab Med. (2003) 127:474–7. doi: 10.5858/2003-127-0474-PAOTB
16. Ahmad M, Naumaan A, Munoz Zuluaga C, and Yoon E. Pleomorphic adenoma of the breast: A rare benign lesion masquerading as a metaplastic breast carcinoma on core-needle biopsy. Cureus. (2023) 15:e38827. doi: 10.7759/cureus.38827
17. Dai Y, Jin Y, Lan A, Ding N, Jiang L, and Liu S. Breast metastasis from rectal signet-ring cell carcinoma: A case report and review of literature. Front Oncol. (2022) 12:873354. doi: 10.3389/fonc.2022.873354
18. Picasso R, Pistoia F, Zaottini F, Sanguinetti S, Calabrese M, Martinoli C, et al. Breast metastases: updates on epidemiology and radiologic findings. Cureus. (2020) 12:e12258. doi: 10.7759/cureus.12258
19. Lin X-Y, Guo L, Lin X, Wang Y, and Zhang G. Concomitant PIK3CA and TP53 mutations in breast cancer: an analysis of clinicopathologic and mutational features, neoadjuvant therapeutic response, and prognosis. J Breast Cancer. (2023) 26:363–77. doi: 10.4048/jbc.2023.26.e30
Keywords: breast tumor, diagnosis, identification, magnetic resonance imaging, pleomorphic adenoma
Citation: He XJ and Lu LL (2026) Breast mass imaging identification of rare pleomorphic adenoma after follow-up of gastric cancer surgery: a case report. Front. Oncol. 16:1759255. doi: 10.3389/fonc.2026.1759255
Received: 03 December 2025; Accepted: 27 January 2026; Revised: 22 January 2026;
Published: 11 February 2026.
Edited by:
Chinmay Jani, University of Miami Health System, United StatesReviewed by:
Jalpan Patel, Mercy Hospital Joplin, United StatesLipisha Agarwal, The University of Vermont Medical Center, United States
Copyright © 2026 He and Lu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: XianJun He, NjU0MjY3NzA2QHFxLmNvbQ==
†These authors have contributed equally to this work